Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
This study has been completed.
Study NCT00653406   Information provided by Janssen Pharmaceutical K.K.

First Received on April 1, 2008.   Last Updated on May 16, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial